X-ray Contrast Imaging Agent (e.g., Computed Tomography, Angiography, Etc.) Patents (Class 424/9.4)
-
Patent number: 11950893Abstract: The present disclosure relates to a method for vascular imaging and determining dynamic vascular parameters of blood flow. According to an embodiment, the present disclosure relates to an apparatus and method of determining dynamic vascular parameters of blood flow, comprising acquiring two-dimensional projection images of a vascular region of interest at a predetermined frequency, the vascular region of interest being downstream of a site of vascular administration of a radio-opaque medium, identifying, within the acquired two-dimensional projection images, heterogeneities of the radio-opaque medium, and determining the dynamic vascular parameters of the blood flow based on spatial movements of the identified heterogeneities of the radio-opaque medium. In an embodiment, the predetermined frequency is greater than 100 Hz.Type: GrantFiled: February 19, 2020Date of Patent: April 9, 2024Assignees: The Research Foundation for the State University of New York, CANON MEDICAL SYSTEMS CORPORATIONInventors: Stephen Rudin, Eugene A. Mensah, Andrew Kuhls-Gilcrist
-
Patent number: 11952425Abstract: Provided herein, in some embodiments, are antibodies, antigen-binding antibody fragments, chimeric antigen receptors (CARs) and bispecific T cell engagers (BiTEs) that bind specifically to B7 homolog 6. Also provided herein are methods of using the same and cells comprising the same.Type: GrantFiled: May 12, 2021Date of Patent: April 9, 2024Assignee: TRUSTEES OF DARTMOUTH COLLEGEInventors: Margaret Ackerman, Casey Hua, Charles Sentman
-
Patent number: 11879953Abstract: A method for evaluating gastric and upper small intestine motility and emptying in a gastrointestinal tract of a subject using magnetic resonance imaging includes administering a contrast agent to the subject; acquiring, using an MRI system, a set of MR data from the subject using a three-dimensional volumetric pulse sequence. The volumetric pulse sequence has a temporal resolution and a spatial resolution configured to facilitate measurement of volumetric and motility parameters. The method further includes reconstructing a set of images using the set of MR data, segmenting each image in the set of images to isolate a region of interest in the gastrointestinal tract of the subject, determining at least one volumetric and motility parameter based on the set of segmented images, and generating a report indicating the at least one volumetric or motility parameter.Type: GrantFiled: May 11, 2020Date of Patent: January 23, 2024Assignee: The General Hospital CorporationInventors: Braden Kuo, Christopher Nguyen, Roberta Sclocco, Vitaly Napadow
-
Patent number: 11857685Abstract: Compositions and methods for treating uterine fibroids are described, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.Type: GrantFiled: April 5, 2021Date of Patent: January 2, 2024Assignees: BioSpecifics Technologies LLC, Duke UniversityInventors: Phyllis Carolyn Leppert, Thomas L. Wegman
-
Patent number: 11859023Abstract: Disclosed herein is method for conjugating a metal chelating agent to a functionalized dextran by reacting a chelator with an aminated dextran backbone, where the chelator comprises a one, and only one, derivatized carboxylic acid group to form a chelator-dextran complex. In certain aspects, the dextran-chelator complex is substantially free of intra- or intermolecular crosslinking. In certain aspects, the functionalized dextran is an amine dextran, an alkynyl dextran, or a thiol dextran. In exemplary implementations, the functionalized dextran is an amine dextran. In further embodiments, one and only one carboxylic acid group on the chelating agent is derivatized as a N-hydroxysuccinimide (NHS) ester.Type: GrantFiled: July 8, 2021Date of Patent: January 2, 2024Assignee: Navidea Biopharmaceuticals, Inc.Inventors: Jeffrey Arnold, David A. Ralph
-
Patent number: 11833170Abstract: Provided are compounds, compositions, methods, and kits for increasing target specificity of a mannosylated carbohydrate polymeric therapeutic or diagnostic compound to reduce or eliminate localization of the mannosylated carbohydrate polymeric therapeutic or diagnostic compound to off-target sites. Mannosylated carbohydrate polymers are synthesized to be modified to be either polyanionic (i.e., net negatively charged) or electrostatically neutral, and using these polyanionic or neutral mannosylated carbohydrate polymers as competitors for polycationic (i.e., net positively charged) mannosylated carbohydrate polymers carrying small molecule drug payloads or imaging moieties to CD206 expressing cells in target tissues, such as tumors or other sites of inflammation.Type: GrantFiled: February 3, 2023Date of Patent: December 5, 2023Assignee: Navidea Biopharmaceuticals, Inc.Inventors: David A. Ralph, Jeffrey Scott Arnold
-
Patent number: 11833761Abstract: In this patent, a method for improving interaction with tangible objects is disclosed. A user wearing an augmented reality head display unit sees tangible objects. A database comprising appropriate orientation and position of a first tangible object with a second tangible object is established. A virtual object to correspond to a second tangible object is generated and registered to the first tangible object with proper positioning and orientation according to the database. The user, by watching the virtual object, can far more easily align the first tangible object with the second tangible object. Thus, this patent can help in construction-type activities.Type: GrantFiled: August 15, 2021Date of Patent: December 5, 2023Inventors: Robert Edwin Douglas, Kathleen Mary Douglas, David Byron Douglas
-
Patent number: 11835522Abstract: In some aspects, the disclosure relates to compositions and method for detection, classification, and treatment of cancer. In some embodiments, the disclosure relates to protease imaging sensors comprising a scaffold linked to an enzyme-specific substrate that includes a first detectable marker capable of being released from the prostate protease sensor when exposed to an enzyme present in cancer and a tumor imaging agent comprising a second detectable marker that is linked to the scaffold. In some embodiments, the disclosure relates to methods of monitor progression of a tumor in a subject based upon detection of detectable markers in a sample obtained from a subject who has been administered a protease imaging sensor, upon detection of a tumor imaging agent, or any combination thereof.Type: GrantFiled: January 17, 2020Date of Patent: December 5, 2023Assignee: Massachusetts Institute of TechnologyInventors: Sangeeta N. Bhatia, Liangliang Hao
-
Patent number: 11801058Abstract: The present specification discloses improved liquid embolic compositions, methods of making such liquid embolic compositions, and methods and uses for such liquid embolic compositions.Type: GrantFiled: March 4, 2021Date of Patent: October 31, 2023Assignee: AccuMedical Beijing Ltd.Inventors: Tai D. Tieu, Hideo Morita
-
Patent number: 11786574Abstract: Provided herein are, inter alia, methods for treating rhinosinusitis with P-glycoprotein inhibitors. A subject having rhinosinusitis is identified and then treated by administration to the subject an effective amount of a P-gp inhibitor. The subject having rhinosinusitis can be identified by one of skill in the art based on known methods, e.g., based on detection of the presence of symptoms, by endoscopy, or by computed tomography. The efficacy of the treatment can be monitored by methods known in the art, e.g., by monitoring symptoms, by endoscopy or computed tomography. The P-glycoprotein inhibitor can be delivered to the subject's nasal passage and sinuses by an inhalation device, by flushing, by spraying, or by an eluting implant surgically placed in the subject's nasal passage or sinuses. The P-glycoprotein inhibitor can also be administered in combination with one or both of a corticosteroid and an antibiotic.Type: GrantFiled: April 15, 2021Date of Patent: October 17, 2023Assignee: Massachusetts Eye and Ear InfirmaryInventor: Benjamin S. Bleier
-
Patent number: 11786191Abstract: Systems and methods for tomosynthesis with an x-ray filter are disclosed. The present technology provides performing breast tomosynthesis in the presence of an x-ray filter. For example, an x-ray filter may be placed between an x-ray source and breast tissue. The filter may proportionally filter out a subset of the energies emitted by the x-ray source. A filter may include characteristics to filter x-ray energies based on a k-edge of a contrast agent introduced into the breast, such that the breast tissue has relatively greater exposure to x-ray energies above the k-edge of the contrast agent to illuminate the contrast agent without substantial illumination of other breast tissue. Thus, tomosynthesis images similar to those obtained using subtraction may be acquired without software-based contrast enhancing techniques.Type: GrantFiled: May 17, 2021Date of Patent: October 17, 2023Assignee: Hologic, Inc.Inventor: Helmut Hartig
-
Patent number: 11747421Abstract: The present application provides a system and method for quantifying perfusion using a dictionary matching approach. In some aspects, the method comprises performing a predetermined pulse sequence using an MRI system to acquire MRI data from the subject after having delivered a dose of a contrast agent to the subject. The method also includes comparing the MRI data to a dictionary to determine perfusion information, and generating, using the perfusion information, a report indicative of perfusion within the subject.Type: GrantFiled: May 20, 2019Date of Patent: September 5, 2023Assignee: Case Western Reserve UniversityInventors: Vikas Gulani, Satyam Ghodasara, Katherine Wright, Nicole Seiberlich, Mark A. Griswold
-
Patent number: 11737644Abstract: A device and method for treating disease involves inserting a scope into a patient's body, the scope having a light source, a camera and a cartridge connected thereto. The cartridge has two chambers separated by membrane, a first one of the chambers containing a virus, and a second one of the chambers being connected to a plurality of microneedles configured for extending into the patient's tissue upon insertion of the scope. Cells from the patient are removed via suction from the microneedles and are deposited in the second chambers. The membrane is then broken to mix the virus with the cells to infect the cells, and the infected cells are then transported back into the patient to treat the disease.Type: GrantFiled: March 16, 2018Date of Patent: August 29, 2023Inventor: Donald Spector
-
Patent number: 11717684Abstract: The present invention relates to the medical field, in particular to the treatment of neurological disorders. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in prevention or treatment of a neurological disease or at least one symptom thereof in a subject when the nanoparticle or nanoparticles' aggregate is exposed to an electric field, wherein the nanoparticle's or nanoparticles' aggregate's material is selected from a conductor material, a semiconductor material, an insulator material with a dielectric constant ?ijk equal to or above 200, and an insulator material with a dielectric constant ?ijk equal to or below 100. It further relates to compositions and kits comprising such nanoparticles and/or nanoparticles' aggregates as well as to uses thereof.Type: GrantFiled: March 18, 2022Date of Patent: August 8, 2023Assignee: NANOBIOTIX S.A.Inventors: Marie-Edith Meyre, Agnès Pottier, Laurent Levy
-
Patent number: 11673970Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair damaged tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to an ischemia-associated molecule; and (b) an activator domain that that detectably modulates the activity of a cellular network.Type: GrantFiled: October 23, 2020Date of Patent: June 13, 2023Assignee: Silver Creek Pharmaceuticals, Inc.Inventors: Ulrik Bjerl Nielsen, Thomas Wickham, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum, Byron DeLaBarre
-
Patent number: 11672875Abstract: Disclosed are capped nanoparticles that are effectively trapped within an aqueous gelling solution to produce stable gels and function as a contrast agent for vascular imaging. The contrast agent has good radioopacity, is inexpensive to produce, and is safe to handle. This provides a new method to image the fine vasculature of biological systems.Type: GrantFiled: March 17, 2021Date of Patent: June 13, 2023Assignee: Saint Louis UniversityInventors: Sarah McBride-Gagyi, Steven W. Buckner, Paul Jelliss, Mohammad Salauddin Kader
-
Patent number: 11547721Abstract: The present invention relates to magnetic nanoparticles based on iron oxide having cubic shape, suitably functionalized for the release of targeting chemotherapeutic agents, i.e. selectively in the tumors being treated The invention also relates to the pharmaceutical compositions having such nanoparticles and to their use in combined oncological therapies of hyperthermia and chemotherapy, useful in particular in the treatment of ovarian tumors.Type: GrantFiled: May 3, 2019Date of Patent: January 10, 2023Assignees: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA, FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, UNIVERSITA DEGLI STUDI DI GENOVA, CONSIGLIO NAZIONALE DELLE RICERCHEInventors: Markus Barthel, Marco Cassani, Mariangela Figini, Juan Granja, Teresa Pellegrino, Alessandra Quarta
-
Patent number: 11534410Abstract: Compositions of nanolipid carrier molecules comprising PEG molecules and solid and liquid lipids wherein the PEG has a molecular weight of between about 1000 and 5000 are described. Methods of administering nanolipid carrier molecules are also described. Also described is a method for treating fungal ocular infections by topical ocular administration of nanolipid carrier molecules comprising PEG molecules and solid and liquid lipids wherein the PEG has a molecular weight of between about 1000 and 5000.Type: GrantFiled: August 5, 2019Date of Patent: December 27, 2022Assignee: UNIVERSITY OF MISSISSIPPIInventors: Soumyajit Majumdar, Akash Patil, Prit Lakhani
-
Patent number: 11529438Abstract: Medical devices, substrates and biologic therapies for bone repair and guided tissue regeneration are disclosed. More particularly, bone graft substitutes and bone void fillers which comprise a porous collagen matrix and calcium deficient hydroxyapatite ceramic granules for delivery of osteoinductive or other therapeutic agents are disclosed.Type: GrantFiled: June 19, 2019Date of Patent: December 20, 2022Assignee: BIOVENTUS, LLCInventors: Christopher Wilson, Eric Vanderploeg, Cheryl Lee, Chase Davis, Howard Seeherman, John Wozney
-
Patent number: 11460772Abstract: A positive resist composition comprising a base polymer comprising recurring units containing an optionally substituted amino group and iodine exhibits a high sensitivity, high resolution, low edge roughness (LER, LWR) and small size variation, and forms a pattern of good profile after exposure and development.Type: GrantFiled: December 17, 2019Date of Patent: October 4, 2022Assignee: SHIN-ETSU CHEMICAL CO., LTD.Inventors: Jun Hatakeyama, Masaki Ohashi
-
Patent number: 11419952Abstract: Described is a versatile surface modification approach to, for example, modularly and orthogonally functionalize nanoparticles (NPs) such as, for example, PEGylated nanoparticles, ith various types of different functional ligands (functional groups) on the NP surface. It enables the synthesis of, for example, penta-functional PEGylated nanoparticles integrating a variety of properties into a single NP, e.g., fluorescence detection, specific cell targeting, radioisotope chelating/labeling, ratiometric pH sensing, and drug delivery, while the overall NP size remains, for example, below 10 nm.Type: GrantFiled: May 21, 2018Date of Patent: August 23, 2022Assignee: CORNELL UNIVERSITYInventors: Kai Ma, Ulrich B. Wiesner
-
Patent number: 11410341Abstract: An image processing system is provided. The image processing system includes a display, a processor, and a memory. The memory stores processor-executable code that when executed by the processor causes receiving an image of a region of interest of a patient with a medical tube or line disposed within the region of interest, detecting the medical tube or line within the image, generating a combined image by superimposing a first graphical marker on the image that indicates an end of the medical tube or line, and displaying the combined image on the display.Type: GrantFiled: November 20, 2020Date of Patent: August 9, 2022Assignee: GE PRECISION HEALTHCARE LLCInventors: Alec Joseph Baenen, Pal Tegzes, Levente Torok, Teri Lynn Fischer, Katelyn Rose Nye, Gireesha Chinthamani Rao
-
Patent number: 11338054Abstract: A method for promoting spine fusion inside intersomatic cages, comprising placing a fusion cage between two vertebral bodies, and injecting a bone cement paste inside said fusion cage, said bone cement paste containing a powder component comprising ?-tricalcium phosphate (?-TCP) particles having an average size greater than or equal to 9 ?m, and a liquid component comprising blood.Type: GrantFiled: August 14, 2019Date of Patent: May 24, 2022Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE NANTES, ONIRIS, GRAFTYSInventors: Jean-Michel Bouler, Olivier Gauthier, Bruno Bujoli, Pascal Janvier, Charlotte Mellier
-
Patent number: 11285674Abstract: A 3D virtual hand is generated and is geo-registered to a tangible object. When the tangible object changes in position, so too does the 3D virtual hand. When the tangible object changes in orientation, so too does the 3D virtual hand. The 3D virtual hand is displayed on an extended reality head display unit. Applications include, but are not limited to, teaching music lessons.Type: GrantFiled: December 6, 2020Date of Patent: March 29, 2022Inventor: Robert Edwin Douglas
-
Patent number: 11253627Abstract: An embolic material contains at least one type of polymer and a liposoluble contrast medium. A method for producing an embolic material includes extruding a raw material that is in a molten state into a solvent, and cooling the raw material so as to solidify the raw material. The raw material contains a polymer and a liposoluble contrast medium.Type: GrantFiled: February 15, 2018Date of Patent: February 22, 2022Assignee: DREAM MEDICAL PARTNERS CORPORATIONInventors: Kenta Bito, Terumitsu Hasebe, Atsushi Hotta
-
Patent number: 11090873Abstract: In this patent, a method and apparatus for improving analysis of a 3D printed object is provided. A first portion of a 3D dataset is selected for 3D printing. The 3D dataset is geo-registered to the 3D printed object. A second portion of the 3D dataset is displayed on a head display unit (HDU). Additional advanced features are discussed herein. An example would be performing 3D printing of a heart from a CT scan and displaying the aorta and inferior vena cave on the HDU geo-registered to the 3D printed heart.Type: GrantFiled: October 21, 2020Date of Patent: August 17, 2021Inventor: Robert Edwin Douglas
-
Patent number: 10912811Abstract: The present invention relates to a composition for improving peripheral circulation and lymph drainage. The composition includes at least one extract of a fatty plant, at least one extract of a plant having astringent properties, and at least one extract of a plant with one or more effects including anti-inflammatory, formation of new, healthy collagen fibrilles, antiseptic properties, antioxidant, neutralizing free radicals, antiedematous, vitaminazing, and stimulating wound healing. The composition may be used to treat at least one of varicose veins, swollen legs, painful legs, stasis dermatitis, swollen arms, indurated arms, hematomas, ecchymosis, periorbital dark circles, periorbital swelling, and hemorrhoids.Type: GrantFiled: October 28, 2014Date of Patent: February 9, 2021Inventors: Felician Stancioiu, Daniela Catanas
-
Patent number: 10898165Abstract: The present invention provides an article or an interface having a distribution of a first partially spherical indentation and at least a second partially spherical indentation contained within the first indentation to form a multi-component or “compound” shape that is referred to as a “compound” or “nested” dimples or indentations. These compound dimples or indentions may be concentric and are etched or otherwise formed into a surface or interface of an article to enhance the ultrasonic imaging. Exemplary articles may be needles of the type used to conduct nerve blocks or the interface may be the surface of such a needle, cannula, catheter, catheter tip or similar article.Type: GrantFiled: January 31, 2019Date of Patent: January 26, 2021Assignee: Avent, Inc.Inventors: Alfred C. Coats, Louis Lupin
-
Patent number: 10898606Abstract: An adhesive free self-fusing material being either of open or closed cell polymer (silicone) based material that can be used to create a permanent elastic band for compression and support dressings. The proprietary polymer material upon contact with itself, initiates a “room temperature” reaction of self-vulcanization with the contact surfaces of itself. This eliminates the need for any adhesives which some patients experience negative reactions. In an example embodiment, the material comprises Vinyl stopped polydimethyl siloxane, amorphous silica, and dimethylpolysiloxane.Type: GrantFiled: May 15, 2019Date of Patent: January 26, 2021Inventors: Michael E. Stein, Sean Dickson
-
Patent number: 10846911Abstract: In this patent, we teach a method and apparatus for displaying flow-type visualization features that move in accordance with fluid dynamics models on extended reality displays. A user is able to select the type of flow of interest and the type of flow of non-interest and then display the type of flow of interest unhindered by the type of flow of non-interest. This technique has applications in medicine, such as modeling flow inside of the carotid artery. Also, outside of the medical field, this technique can have applications, such as in aeronautical engineering.Type: GrantFiled: February 2, 2020Date of Patent: November 24, 2020Inventor: Robert Edwin Douglas
-
Patent number: 10495968Abstract: A monomer having formula (I): wherein in formula (I), groups and variables are the same as described in the specification.Type: GrantFiled: June 15, 2017Date of Patent: December 3, 2019Assignee: ROHM AND HAAS ELECTRONIC MATERIALS LLCInventors: Emad Aqad, James W. Thackeray, James F. Cameron
-
Patent number: 10487037Abstract: A process for preparing an iodinated fatty acid ethyl ester includes steps of subjecting a fatty acid ester to a protonation reaction with phosphoric acid to form a protonated fatty acid ester, and subjecting the protonated fatty acid ester to an iodination reaction with an alkali metal iodide to obtain an iodinated fatty acid ester.Type: GrantFiled: July 10, 2018Date of Patent: November 26, 2019Assignee: Food Industry Research and Development InstituteInventors: Chih-Chiang Lin, Chih-Hong Tung, Yan-Hwa Chu, Ding-Yuan Su
-
Patent number: 10485780Abstract: The invention features methods of treating a proliferative disorder characterized by elevated Pin1 marker levels and/or reduced Pin1 Ser71 phosphorylation in a subject by administering a retinoic acid compound. Additionally, the invention features methods of treating proliferative disorders (e.g., proliferative disorders characterized by elevated Pin1 marker levels) by administering a retinoic acid compound in combination with another anti-proliferative compound. Finally, the invention also features methods including high-throughput screens for discovering and validating Pin1 inhibitors.Type: GrantFiled: March 14, 2012Date of Patent: November 26, 2019Assignee: Beth Israel Deaconess Medical Center, Inc.Inventors: Kun Ping Lu, Shuo Wei, Xiao Zhen Zhou
-
Patent number: 10478512Abstract: The present invention relates to compositions for and methods of optically imaging tissues or cells using imaging agents having desirable in vivo properties that result in improved signal-to-background ratio.Type: GrantFiled: February 23, 2018Date of Patent: November 19, 2019Assignees: Beth Israel Deaconess Medical Center, Inc., Georgia State University Research Foundation Inc.Inventors: John V. Frangioni, Maged M. Henary
-
Patent number: 10311273Abstract: A thermal tag includes a power source to generate current along a resistive path and a plurality of infrared-emitting features positioned along the resistive path to emit infrared light along an infrared-emitting pattern, wherein the plurality of infrared-emitting features include one or more infrared-emitting stripes on a first surface of the thermal tag defining a pattern region and a plurality of infrared-emitting dots within a portion of the pattern region to provide a thermal-diffusion resistant pattern for activity monitoring.Type: GrantFiled: October 18, 2016Date of Patent: June 4, 2019Assignee: International Business Machines CorporationInventors: Li-Wen Hung, Jui-Hsin Lai
-
Patent number: 10276735Abstract: A semiconductor nanocrystal include a first I-III-VI semiconductor material and have a luminescence quantum yield of at least 10%, at least 20%, or at least 30%. The nanocrystal can be substantially free of toxic elements. Populations of the nanocrystals can have an emission FWHM of no greater than 0.35 eV.Type: GrantFiled: July 26, 2017Date of Patent: April 30, 2019Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Peter Matthew Allen, Moungi G. Bawendi
-
Patent number: 10231702Abstract: The present invention provides an article or an interface having a distribution of a first partially spherical indentation and at least a second partially spherical indentation contained within the first indentation to form a multi-component or “compound” shape that is referred to as a “compound” or “nested” dimples or indentations. These compound dimples or indentions may be concentric and are etched or otherwise formed into a surface or interface of an article to enhance the ultrasonic imaging. Exemplary articles may be needles of the type used to conduct nerve blocks or the interface may be the surface of such a needle, cannula, catheter, catheter tip or similar article.Type: GrantFiled: August 21, 2018Date of Patent: March 19, 2019Assignee: Avent, Inc.Inventors: Alfred C. Coats, Louis Lupin
-
Patent number: 10098599Abstract: A colon imaging system, including an imaging capsule, having: a. a radiation source providing X-Ray and gamma radiation with energies sufficient to induce X-Ray fluorescence from nanoparticles that adhere to cancerous tissue, and which were administered to a patient in a solution prior to examining the colon with the imaging capsule; b. a detector for detecting particle energy of particles emitted responsive to the provided radiation and forming count information disclosing a number of particles detected for each energy level; c. a transceiver for transferring the count information to an external computer for analysis, and also having a computer for constructing images of an inside of the colon based on the count information; wherein the images provide an indication of locations in the colon of which the nanoparticles adhere to.Type: GrantFiled: October 12, 2015Date of Patent: October 16, 2018Assignee: CHECK-CAP LTD.Inventors: Yoav Kimchy, Shlomo Lewkowicz
-
Patent number: 10089728Abstract: Feature amount calculation unit determines that the diagnosis target is a bone portion of a subject, and calculates a feature amount of a density of the radiation image based on a soft region in a radiation image acquired by irradiating a photographic subject with radiation. An image processing unit performs image processing including gradation processing on the radiation image, such that the feature amount becomes the target density, to acquire a processed radiation image.Type: GrantFiled: January 20, 2016Date of Patent: October 2, 2018Assignee: FUJIFILM CorporationInventors: Keigo Nakamura, Tomoyuki Takahashi
-
Patent number: 10076307Abstract: The present invention provides an article or an interface having a distribution of a first partially spherical indentation and at least a second partially spherical indentation contained within the first indentation to form a multi-component or “compound” shape that is referred to as a “compound” or “nested” dimples or indentations. These compound dimples or indentions may be concentric and are etched or otherwise formed into a surface or interface of an article to enhance the ultrasonic imaging. Exemplary articles may be needles of the type used to conduct nerve blocks or the interface may be the surface of such a needle, cannula, catheter, catheter tip or similar article.Type: GrantFiled: June 18, 2014Date of Patent: September 18, 2018Assignee: Avent, Inc.Inventors: Alfred C. Coats, Louis Lupin
-
Patent number: 10022459Abstract: A medical tissue-marker which enables the identification of a location even from the outside of an organ, can remain topical over a long period, and enables the easy identification of a marked location within the whole organ; also a manufacturing method for the medical tissue-marker. The medical tissue-marker includes a vesicle formed by the synthesis of a phospholipid and a near infrared fluorescent dye, and an emulsion formed by the synthesis of the phospholipid and an X-ray contrast medium, and has agglomerated clusters wherein the vesicle and the emulsion are contained in a hydrophilic solvent and a plurality of capsules are formed by use of an emulsifier.Type: GrantFiled: May 31, 2012Date of Patent: July 17, 2018Assignee: NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITYInventors: Hideki Hayashi, Hirosuke Hatayama, Masanori Fujinami, Taro Toyota
-
Patent number: 10004475Abstract: Disclosed are embodiments of methods and devices for providing enhanced echogenicity to medical devices. The method includes rolling an impression roller having a plurality of protrusions and an outer surface against a medical device. The protrusions create depressions in the surface of the medical device. A guide roller forms a ridge of the depression into the depression to create a lobe. The lobe forms a pocket between a bottom surface of the depression and the lobe.Type: GrantFiled: March 6, 2014Date of Patent: June 26, 2018Assignee: Muffin IncorporatedInventor: Benjaman B. Quearry
-
Patent number: 9827268Abstract: The present invention provides a curable calcium phosphate composition for biological hard tissue repair that yields a cured product excellent in durability in a wet environment such as in a body or an oral cavity. The present invention relates to a curable calcium phosphate composition for biological hard tissue repair, including tetracalcium phosphate particles (A), calcium hydrogen phosphate particles (B), calcium carbonate particles (C), and water (D), the curable calcium phosphate composition including 5 to 75 parts by weight of the tetracalcium phosphate particles (A), 10 to 70 parts by weight of the calcium hydrogen phosphate particles (B), and 2 to 50 parts by weight of the calcium carbonate particles (C) per 100 parts by weight of the total of the tetracalcium phosphate particles (A), the calcium hydrogen phosphate particles (B), and the calcium carbonate particles (C).Type: GrantFiled: August 4, 2014Date of Patent: November 28, 2017Assignee: KURARAY NORITAKE DENTAL INC.Inventors: Kenji Hatanaka, Shumei Ishihara
-
Patent number: 9775904Abstract: The present invention relates to dual GLP-1/glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.Type: GrantFiled: April 6, 2015Date of Patent: October 3, 2017Assignee: SANOFIInventors: Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin, Michael Wagner
-
Patent number: 9758561Abstract: The present invention relates to dual GLP-1/glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.Type: GrantFiled: April 6, 2015Date of Patent: September 12, 2017Assignee: SANOFIInventors: Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin, Michael Wagner, Dieter Kadereit
-
Patent number: 9579380Abstract: A method of enhancing the permeability of a biological membrane, including the skin or mucosa of an animal or the outer layer of a plant to a permeant is described utilizing microporation of selected depth and optionally one or more of sonic, electromagnetic, mechanical and thermal energy and a chemical enhancer. Microporation is accomplished to form a micropore of selected depth in the biological membrane and the porated site is contacted with the permeant. Additional permeation enhancement measures may be applied to the site to enhance both the flux rate of the permeant into the organism through the micropores as well as into targeted tissues within the organism.Type: GrantFiled: March 16, 2005Date of Patent: February 28, 2017Assignee: NTT DENKO CORPORATIONInventor: Jonathan A. Eppstein
-
Patent number: 9351943Abstract: The present invention is directed to compositions and methods targeting tissue resident cells, such as fibroblasts, in a subject harboring conditions or at risk for conditions that would benefit from anti-fibroblastic therapy. The present invention relates to the use of fluorochemical compositions and methods of delivery that result in retention of the fluorochemical composition and any bioactive agent delivered in combination with the fluorochemical composition.Type: GrantFiled: July 1, 2011Date of Patent: May 31, 2016Inventor: Matthew T. McLeay
-
Patent number: 9340636Abstract: The invention includes a composition comprising a vinyl sulfone monomer, a thiol monomer and an acrylate monomer. In one embodiment, the thiol monomer reacts with the vinyl sulfone monomer preferentially over the acrylate monomer, and this differential selectivity allows for the control of the architecture of crosslinking polymer network. The invention further includes a composition comprising an electrophilic monomer, a nucleophilic monomer, a nucleophilic catalyst and an acid, wherein the concentrations of the nucleophilic catalyst and acid are selected as to provide a specific induction time for the polymerization reaction of the composition.Type: GrantFiled: July 25, 2014Date of Patent: May 17, 2016Assignee: The Regents of the University of Colorado, a body corporateInventors: Christopher N. Bowman, Devatha P. Nair, Maciej Podgorski, Shunsuke Chatani
-
Patent number: 9244060Abstract: Methods for identifying defects in blood vessels and treating such defects are provided. The methods comprise administering to a patient a composition comprising a labeled delivery ligand capable of preferentially accumulating at or near blood vessels defects. In some embodiments, the delivery ligand may carry one or more active agents to the defect.Type: GrantFiled: March 26, 2009Date of Patent: January 26, 2016Assignee: Warsaw Orthopedic, Inc.Inventors: Josee Roy, Roger Harrington
-
Patent number: 9161998Abstract: The invention relates to a method and a kit for preparing a radiopharmaceutical, the method comprising the steps: elution of a 68Ge/68Ga-Generator using hydrochloric acid as an eluent for obtaining a generator eluate comprising 68Gallium, feeding the generator eluate through a cation exchange cartridge, which collects the 68Gallium, separating the used eluent, eluting the 68Gallium from the cation exchange cartridge using a solution comprising sodium chloride and hydrochloric acid and feeding the resulting eluate into an aqueous precursor mixture comprising at least a labelling precursor thereby forming a reaction solution.Type: GrantFiled: May 18, 2012Date of Patent: October 20, 2015Assignee: Zentralklinik Bad Berka GmbHInventor: Dirk Müller